TSH BIOPHARM CORPORATION LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of 8432 for the last quarter is 443.04 M TWD, and it's 258.13% higher compared to the previous quarter. The net income of Q4 23 is 19.55 M TWD.